| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1011982874 |
| P356 | DOI | 10.1038/SJ.NPP.1300666 |
| P698 | PubMed publication ID | 15668721 |
| P5875 | ResearchGate publication ID | 8062462 |
| P50 | author | Undine Lang | Q5394305 |
| P2093 | author name string | Rainer Hellweg | |
| Jürgen Gallinat | |||
| P2860 | cites work | The catecholamine hypothesis of affective disorders: a review of supporting evidence | Q22306296 |
| Up-regulation of the neuronal serotoninergic phenotype in vitro: BDNF and cAMP share Trk B-dependent mechanisms | Q28568501 | ||
| Electroconvulsive shock regulates serotonin transporter mRNA expression in rat raphe nucleus | Q32111739 | ||
| Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). | Q33179738 | ||
| Neurotrophins and depression | Q33547892 | ||
| Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus | Q33925002 | ||
| A molecular and cellular theory of depression | Q34064955 | ||
| Serotonergic dysfunction, negative mood states, and response to alcohol | Q34236249 | ||
| Serotonin transporter and GABAA alpha 6 receptor variants are associated with neuroticism | Q34292628 | ||
| Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex | Q34456117 | ||
| The serotonin syndrome scale: first results on validity. | Q34749913 | ||
| Antidepressants and neuroplasticity | Q34785757 | ||
| Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression | Q35111592 | ||
| Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders | Q35120257 | ||
| Baseline studies on transmitter substances in cerebrospinal fluid in depression | Q39472157 | ||
| Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis | Q40852012 | ||
| Developmental Regulation of Early Serotonergic Neuronal Differentiation: The Role of Brain-Derived Neurotrophic Factor and Membrane Depolarization | Q41331056 | ||
| Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus | Q42526600 | ||
| A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression | Q42694857 | ||
| Influence of physical exercise on 5-HT1A receptor- and anxiety-related behaviours. | Q43327071 | ||
| 5HT2 receptor changes in major depression. | Q43586202 | ||
| Developmental impairment of auditory evoked N1/P2 component in rats undernourished in utero: its relation to brain serotonin activity | Q43596518 | ||
| Motor activity increases tryptophan, 5-hydroxyindoleacetic acid, and homovanillic acid in ventricular cerebrospinal fluid of the conscious rat. | Q43982350 | ||
| Human platelets contain brain-derived neurotrophic factor. | Q44247974 | ||
| Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. | Q44315060 | ||
| Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing | Q44357534 | ||
| Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation | Q44614312 | ||
| Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain | Q44748311 | ||
| Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression | Q44927019 | ||
| Electrophysiological indication for a link between serotonergic neurotransmission and personality in alcoholism | Q45711955 | ||
| BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits | Q48089459 | ||
| Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. | Q48281682 | ||
| Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography | Q48338717 | ||
| Exercise training: Significance of regional alterations in serotonin metabolism of rat brain in relation to antidepressant effect of exercise | Q48404909 | ||
| Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia | Q48426190 | ||
| Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets | Q48528817 | ||
| Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. | Q48635095 | ||
| Auditory-evoked potentials as indicator of brain serotonergic activity--first evidence in behaving cats | Q48683420 | ||
| Effects of tryptophan and/or acute running on extracellular 5-HT and 5-HIAA levels in the hippocampus of food-deprived rats | Q48779092 | ||
| Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). | Q48824073 | ||
| BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. | Q49111574 | ||
| BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. | Q50514709 | ||
| Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. | Q50755884 | ||
| Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. | Q52012874 | ||
| Biochemistry of the Augmenting-Reducing Response in Visual Evoked Potentials | Q52103096 | ||
| The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra. | Q52880163 | ||
| The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. | Q52970619 | ||
| Auditory Evoked Potentials Reflect Serotonergic Neuronal Activity—A Study in Behaving Cats Administered Drugs Acting on 5-HT1A Autoreceptors in the Dorsal Raphe Nucleus | Q58444785 | ||
| High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users | Q60630108 | ||
| The effect of placebo and tricyclic antidepressants on cortical evoked potentials in depressed patients | Q66939184 | ||
| Increased serotonin-2 binding sites in frontal cortex of suicide victims | Q72544244 | ||
| Sensation seeking and affective disorders: characteristics in the intensity dependence of acoustic evoked potentials | Q73341411 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | signal processing | Q208163 |
| P304 | page(s) | 1148-1153 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing | |
| P478 | volume | 30 |
| Q36600804 | A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia |
| Q28486109 | Association between BDNF gene polymorphisms and serotonergic activity using loudness dependence of auditory evoked potentials in healthy subjects |
| Q34421673 | Association of a functional BDNF polymorphism and anxiety-related personality traits |
| Q48329466 | Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking |
| Q51481116 | Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants. |
| Q33882680 | Evidence of associations between brain-derived neurotrophic factor (BDNF) serum levels and gene polymorphisms with tinnitus |
| Q46900358 | Further evidence for an association of 5-HTTLPR with intensity dependence of auditory-evoked potentials |
| Q43224166 | Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement |
| Q46715763 | Is the loudness dependence of the auditory evoked potential a sensitive and selective in vivo marker of central serotonergic function? |
| Q53261278 | Loudness dependence of auditory evoked potentials (LDAEP) correlates with the availability of dopamine transporters and serotonin transporters in healthy volunteers—a two isotopes SPECT study |
| Q48385064 | Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker for affective disorders? |
| Q30441204 | Serum BDNF levels in relation to illness severity, suicide attempts, and central serotonin activity in patients with major depressive disorder: a pilot study |
| Q37242731 | Serum brain-derived neurotrophic factor and peripheral indicators of the serotonin system in underweight and weight-recovered adolescent girls and women with anorexia nervosa. |
| Q88488937 | Serum brain-derived neurotrophic factor level and exercise tolerance complement each other in predicting the prognosis of patients with heart failure |
Search more.